Paralytics


Neuromuscular-blocking agents also known as paralytics block neuromuscular transmission at neuromuscular junction, causing loss of motion of skeletal muscles. This is accomplished similarly by acting presynaptically through the inhibition of acetylcholine (ACh) synthesis and by acting postsynaptically at the acetylcholine receptors of the motor nerve end-plate. While a few medications act presynaptically, (for example, botulinum toxin and tetanus poison), those of current clinical significance work postsynaptically. Because the appropriate dose of neuromuscular-blocking medication may paralyze muscles required for breathing (i.e., the diaphragm), mechanical ventilation should to be provided to maintain adequate respiration.


    Related Conference of Paralytics

    April 18-19, 2024

    7th World Congress on Surgeons

    Dubai, UAE
    August 13-14, 2024

    10th International Conference on Surgeons

    Rome, Italy
    September 16-17, 2024

    2nd Annual Conference on Surgery

    Paris, France
    October 22-23, 2024

    2nd Global Summit on Geriatrics & Aging

    Paris, France
    November 28-29, 2024

    15th European Conference on Surgery & Cosmetology

    Paris, France

    Paralytics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in